Search - tctmd.com

Displaying 741 - 760 of 850

Sort: Relevancy | Date

News Daily News

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

March 05, 2012

News Daily News

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

March 05, 2012

News Daily News

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

February 07, 2012

News Industry News

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 17, 2012

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Daily News

Study Shines Spotlight on US Readmissions After STEMI

Yael L. Maxwell

January 04, 2012

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Daily News

Most Cath Lab Activations by Emergency Personnel for Suspected STEMI Appropriate

December 11, 2011

News Daily News

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

Leah Lawrence

December 08, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Daily News

STEMI Patients Not Achieving Recommended Transfer Times for PCI

L.A. McKeown

December 05, 2011

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Conference News

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

November 15, 2011

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

Advertisement

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Study Shines Spotlight on US Readmissions After STEMI

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

Most Cath Lab Activations by Emergency Personnel for Suspected STEMI Appropriate

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

STEMI Patients Not Achieving Recommended Transfer Times for PCI

Hospital Readmission Post-PCI Linked to Increased Mortality

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

No LateTIME Benefit for Cell Therapy After Primary PCI

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Two New SES Show Improvement Over First-Generation Stents

Polymer-free drug eluting stents result in lower in-stent late loss

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content